Global economic freedom declines for fourth straight year
"Global economic freedom peaked in 2019 but has declined in each of the four years since then, which hasn't happened since we began measuring economic freedom more than 25 years ago," said
Economic freedom—the degree to which individuals are allowed to make their own decisions about what to buy, where to work and whether to start a business—is fundamental to prosperity. Economic freedom measures openness to trade, tax and regulatory burdens, government spending, and the soundness of a country's money.
In 2023 (the latest year of available data),
Crucially, because the data are from 2023, they do not reflect any consequences from the current trade war (though the report does include a chapter on the trade war's potential effects on economic freedom in the
The rankings of other major countries include the
The 10 lowest-ranked countries were
People living in countries with high levels of economic freedom enjoy greater prosperity, more political and civil liberties, and longer lives.
For example, in 2023 per-person GDP (an indicator of living standards) in countries in the top 25 per cent of economic freedom was
And poverty rates are lower. In the most-economically free quartile, 2 per cent of the population experienced extreme poverty (living on less than
Finally, life expectancy is 79 years in the freest countries compared to 62 years in the least free.
"Where people are free to pursue their own opportunities and make their own economic choices, they lead more prosperous, happier and healthier lives," Mitchell said.
To arrange media interviews or for more information, please contact:
Follow the Fraser Institute on Twitter and Facebook
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in
View original content to download multimedia:https://www.prnewswire.com/news-releases/global-economic-freedom-declines-for-fourth-straight-year-302566785.html
SOURCE The Fraser Institute
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akeso's AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline
- Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
- Crypto News Today: VoidTrace AI Prepares September 4 Presale as Cross-Chain AI Intelligence Platform Moves Toward Launch
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share